\Illllllllllllllklllll ‘IIIIIIIIIIIII IIIIIIII IIIIIII}I l‘llll II III

IIIIIIIIIIIIIIIIIIIIIIIIII III IIIIIIIIIIIII IIIIIIIIIII IIIIII

ICE) C) r 3
I/JL/LML CLLQQ Wet WMQbSSIS

@112 (9 JWW awe
qt) 6767/14

III

Concerning

Summary pathology report

Left orchidectomy; nonseminoma (EC 60%. MT+iT 30%, YST 10%, scattered trophoblastic

giant cells); diameter 5 cm; no angio—invasion; no invasion of rete testis; tumor conﬁned to
testis.

Date of procurement (= date of orchidectomy):

pathologist

professor of pathoiogy

ﬂéﬁfumoriﬁ' ,IOW 75$, a/K Mme/.147 5W,

Jiékmu 507/
WM3“§I“
mefg

can
Reviewer

 

 

 

 

TCGA Pathologic Diagnosis Discrepancy Form

V4. (30

 

 

mm The TCGA Pathologic Diagnosis Discrepancy Form should be completed when the pathologic diagnosis
documented on the initial pathology report for a case submitted for TCGA is inconsistent with the diagnosis provided on the
Case Quality Control Form completed for the submitted case.

 

 

 

Tissue Source Site (T55): T85 Identiﬁer: TSS Unique Patient Identiﬁer:
Completed By (Interviewer Name Completed Date: __
lDiagnosis Information

# Data Element Entry Alternatives Working Instructions

 

Pathologic Diagnosis

EC (60%), MT plus IT (30%],
YST (10%) + Trophoblastic giant cells

Provide the diagnosis / histologic subtype(s) documented on
the initial pathology report for this case. If the histology for

 

 

1 Provided on Initial this case is mixed, provide all listed subtypes.
Pathology Report
. . YST (6 09s) . EC (30%) , MT (5%) , IT (5%) Provide the histologic features selected on the TCGA Case
:{hlstologltlt featIIIIICIIS 3f Quality Control Form completed for this case.
e samp e provr e
2 for TCGA, as reﬂected
on the CQCF.

 

 

Discrepancy between Pathology Report and Case Quality Control Form

 

 

 

 

 

 

3 Provide the reason for Due to the histological heterogeneous Provide a reason describing why the diagnosis on the initial
the discrepancy of reinstating:assistants:stills...
between the pathology representation of the different I
report and the TCGA elements can and is in fact expected
Case Quality COHUIOI to differ between the FFPE and frozen
Form- samples of the same case .

However , the components are monoclonal
in origin .
Name of TSS Reviewing Provide the name of the pathologist who reviewed this case
4 Pathologist or I" TCGA‘
Biorepository Director

 

 

I acknowledge that the above information provided by my institution is true and correct and has been quality controlled.

 

TSS Reviewing Pathologist or Biorepository Director

Date

I acknowledge that the above information provided by my institution is true and correct and has been quality controlled. The Attending Pathologist or the
Department Chairman has been informed or is aware of the above discrepancy in diagnoses.

 

Principal Investigator Signature

Date

 

 

 

